Meta Pixel

Kurk Functional Foods

United Kingdom|Biotechnology

Overview

We have created the most effective alternative to Ibuprofen, from 100% plants.

Founded by two cancer survivors (and best friends) Dr Harrison Weisinger and Trent Scanlen, we are vertically integrated and are well positioned to scale rapidly into two huge markets worldwide - Herbal medicine ($550B) and Functional Foods ($309B).

After 4 years of R&D in our purpose built lab in Twickenham, we have cleanly distilled curcumin into a micellar emulsion and combined it with other functional plant extracts to create a delicious drink in 3 flavours. 

We have achieved over £3.5m in online sales and have pioneered incredible scientific and medical results. We now want to scale our KURK brand, enter retail and unlock distribution partnerships. 

Company Highlights

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.



Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.



Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat f


Open an account to get
access to more details

Problem and Solution

Cras eleifend purus vitae mattis imperdiet.



Integer fringilla mi ut sem tincidunt, in sagittis odio mollis. Suspendisse a diam lectus. Cras at suscipit risu


Open an account to get
access to more details

Competitive Advantage

Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.

Duis vitae mi neque.



Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.



Proin neque lacus, semper vel ex at, eleifend rhoncus est.

Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui placerat fermentum. Maecenas malesuada viverra leo eu bibendum. Nam


Open an account to get
access to more details

Current Shareholders & Investors

Cras eleifend purus vitae mattis imperdiet.



Integer fringilla mi ut sem tincidunt, in sagittis odi


Open an account to get
access to more details

Join over 45,000+ sophisticated investors

Join Now